Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension

Libor Kopkan, Zuzana Husková, Alexandra Sporková, Šárka Varcabová, Zuzana Honetschlägerová, Sung Hee Hwang, Hsing-Ju Tsai, Bruce D. Hammock, John D. Imig, Herbert J. Kramer, Marcela Bürgelová, Alžběta Vojtíšková, Petr Kujal, Zdenka Vernerová,...

. 2012 ; 35 (6) : 595-607.

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14041004

Grantová podpora
NT11230 MZ0 CEP - Centrální evidence projektů

OBJECTIVE: The present study was performed to examine whether the blood pressure (BP)-lowering effects of soluble epoxide hydrolase (sEH) inhibition in two-kidney, one-clip (2K1C) Goldblatt hypertension are nitric oxide (NO) dependent. METHODS: Mice lacking the endothelial NO synthase (eNOS) gene (eNOS-/-) and their wild-type controls (eNOS+/+) underwent clipping of one renal artery. BP was monitored by radiotelemetry and the treatment with the sEH inhibitor cis-4-[4-(3-adamantan-1-yl-ureido)cyclohex-yloxy]-benzoic acid (c-AUCB) was initiated on day 25 after clipping and lasted for 14 days. Renal concentrations of epoxyeicosatrienoic acids (EETs) and their inactive metabolite dihydroxyeicosatrienoic acids (DHETs) were measured in the nonclipped kidney. Renal NO synthase (NOS) activity was determined by measuring the rate of formation of L-[(14)C]citruline from L-[(14)C]arginine. RESULTS: Treatment with the sEH inhibitor elicited similar BP decreases that were associated with increases in daily sodium excretion in 2K1C eNOS+/+ as well as 2K1C eNOS-/- mice. In addition, treatment with the sEH inhibitor increased the ratio of EETs/DHETs in the nonclipped kidney of 2K1C eNOS+/+ as well as 2K1C eNOS-/- mice. Treatment with the sEH inhibitor did not alter renal NOS activity in any of the experimental groups. CONCLUSIONS: Collectively, our present data suggest that the BP-lowering effects of chronic sEH inhibition in 2K1C mice are mainly associated with normalization of the reduced availability of biologically active EETs in the nonclipped kidney and their direct natriuretic actions.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14041004
003      
CZ-PrNML
005      
20150109101154.0
007      
ta
008      
140107s2012 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000339883 $2 doi
035    __
$a (PubMed)22948718
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kopkan, Libor $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
245    10
$a Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension / $c Libor Kopkan, Zuzana Husková, Alexandra Sporková, Šárka Varcabová, Zuzana Honetschlägerová, Sung Hee Hwang, Hsing-Ju Tsai, Bruce D. Hammock, John D. Imig, Herbert J. Kramer, Marcela Bürgelová, Alžběta Vojtíšková, Petr Kujal, Zdenka Vernerová, Luděk Červenka
520    9_
$a OBJECTIVE: The present study was performed to examine whether the blood pressure (BP)-lowering effects of soluble epoxide hydrolase (sEH) inhibition in two-kidney, one-clip (2K1C) Goldblatt hypertension are nitric oxide (NO) dependent. METHODS: Mice lacking the endothelial NO synthase (eNOS) gene (eNOS-/-) and their wild-type controls (eNOS+/+) underwent clipping of one renal artery. BP was monitored by radiotelemetry and the treatment with the sEH inhibitor cis-4-[4-(3-adamantan-1-yl-ureido)cyclohex-yloxy]-benzoic acid (c-AUCB) was initiated on day 25 after clipping and lasted for 14 days. Renal concentrations of epoxyeicosatrienoic acids (EETs) and their inactive metabolite dihydroxyeicosatrienoic acids (DHETs) were measured in the nonclipped kidney. Renal NO synthase (NOS) activity was determined by measuring the rate of formation of L-[(14)C]citruline from L-[(14)C]arginine. RESULTS: Treatment with the sEH inhibitor elicited similar BP decreases that were associated with increases in daily sodium excretion in 2K1C eNOS+/+ as well as 2K1C eNOS-/- mice. In addition, treatment with the sEH inhibitor increased the ratio of EETs/DHETs in the nonclipped kidney of 2K1C eNOS+/+ as well as 2K1C eNOS-/- mice. Treatment with the sEH inhibitor did not alter renal NOS activity in any of the experimental groups. CONCLUSIONS: Collectively, our present data suggest that the BP-lowering effects of chronic sEH inhibition in 2K1C mice are mainly associated with normalization of the reduced availability of biologically active EETs in the nonclipped kidney and their direct natriuretic actions.
650    _2
$a zvířata $7 D000818
650    _2
$a antihypertenziva $x farmakologie $x terapeutické užití $7 D000959
650    _2
$a inhibitory enzymů $x farmakologie $x terapeutické užití $7 D004791
650    _2
$a epoxid hydrolasy $x antagonisté a inhibitory $x metabolismus $7 D004851
650    _2
$a renovaskulární hypertenze $x farmakoterapie $x enzymologie $7 D006978
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši knockoutované $7 D018345
650    12
$a oxid dusnatý $x metabolismus $7 D009569
650    _2
$a synthasa oxidu dusnatého, typ III $x nedostatek $7 D052250
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Husková, Zuzana $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Sporková, Alexandra $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Varcabová, Šárka $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Honetschlägerová, Zuzana $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Hwang, Sung Hee $u Department of Entomology and UCD Cancer Center, University of California, Davis, Calif., USA
700    1_
$a Tsai, Hsing-Ju $u Department of Entomology and UCD Cancer Center, University of California, Davis, Calif., USA
700    1_
$a Hammock, Bruce D. $u Department of Entomology and UCD Cancer Center, University of California, Davis, Calif., USA
700    1_
$a Imig, John D. $u Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisc., USA
700    1_
$a Kramer, Herbert J. $u Section of Nephrology, Medical Policlinic, Department of Medicine, University of Bonn, Bonn, Germany
700    1_
$a Bürgelová, Marcela $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Vojtíšková, Alžběta $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kujal, Petr $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Vernerová, Zdenka $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Department of Pathology, 3rd Faculty of Medicine, Prague, Czech Republic
700    1_
$a Červenka, Luděk $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Department of Physiology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00003064 $t Kidney & blood pressure research $x 1423-0143 $g Roč. 35, č. 6 (2012), s. 595-607
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22948718 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140107 $b ABA008
991    __
$a 20150109101333 $b ABA008
999    __
$a ok $b bmc $g 1005400 $s 839516
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 35 $c 6 $d 595-607 $i 1423-0143 $m Kidney & blood pressure research $n Kidney Blood Press Res $x MED00003064
GRA    __
$a NT11230 $p MZ0
LZP    __
$a Pubmed-20140107

Najít záznam

Citační ukazatele

Možnosti archivace